Mihaela Glavan

Metabolite Profiling of the Gut–Renal–Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients

F. Bob, C. Socaciu, A. Vlad, 2023, International journal of molecular sciences.

Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney Disease

F. Bob, D. Muntean, C. Socaciu, 2023, Biomedicines.

Cancer before and after the start of hemodialysis and association with mortality – an Eastern-European multicenter study

B. Timar, F. Bob, A. Schiller, 2023, Renal failure.

Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

F. Bob, D. Muntean, A. Vlad, 2023, International journal of molecular sciences.

Metabolites Potentially Derived from Gut Microbiota Associated with Podocyte, Proximal Tubule, and Renal and Cerebrovascular Endothelial Damage in Early Diabetic Kidney Disease in T2DM Patients

F. Bob, C. Socaciu, A. Vlad, 2023, Metabolites.

Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

F. Bob, C. Socaciu, A. Vlad, 2023, Biomolecules.

Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease

F. Bob, C. Socaciu, A. Vlad, 2023, Biomedicines.